Science
SARS-CoV-2 neutralizing antibody structures inform therapeutic strategies – Nature.com
The COVID-19 pandemic presents an urgent health crisis. Human neutralizing antibodies (hNAbs) that target the host ACE2 receptor-binding domain (RBD) of the SAR…
Christopher O. Barnes, Claudia A. Jette, Morgan E. Abernathy, Kim-Marie A. Dam, Shannon R. Esswein, Harry B. Gristick, Kathryn E. Huey-Tubman, Yu E. Lee, Anthony P. West Jr & Pamela J. Bjorkman
Andrey G. Malyutin
Continue Reading
